Skip to content

Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes

Metabolic and Neurological Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04955691
Enrollment
19
Registered
2021-07-09
Start date
2021-07-29
Completion date
2024-08-06
Last updated
2025-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type1diabetes, Low Carbohydrate Diet

Brief summary

As more adolescents with type 1 diabetes (T1D) opt to follow very low carbohydrate diets to improve glucose control, it is becoming increasingly important to study the metabolic and neurological changes that occur on these diets and how these effect patient safety. Understanding the impact of dietary changes on metabolic and neurological factors will help guide clinical advice about the overall safety and efficacy of these diets in the pediatric T1D population. This work will be the basis of future studies testing dietary interventions to improve glycemic control and ensure that these dietary interventions are safe for growing youth with T1D.

Detailed description

The primary objective of this randomized crossover study is to determine whether a very low carbohydrate diet improves glycemic changes (measured by continuous glucose monitors) when compared to a standard carbohydrate diet in youth with type 1 diabetes. The secondary objectives of the study are to compare metabolic changes after 2 weeks on each diet using the 2-step hyperinsulinemic euglycemic-hypoglycemic clamp and stable isotope infusions. The euglycemic portion of the clamp will allow us to determine the hepatic glucose production and adipose tissue lipolysis. Secondary objectives also include measuring the neurohormonal response to hypoglycemia after 2 weeks on each diet.

Interventions

OTHERlow carbohydrate diet

Participants will engage in a diet that limits carbohydrate intake to 15% of total daily calories for 2 weeks.

Participants will engage in a diet that recommends standard carbohydrate intake with respect to total daily calories for 2 weeks.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of type 1 diabetes for at least 1 year * Hemoglobin A1c level \< 10% within the past 2 months * Provision of signed and dated informed consent form by the adult (if person is at least 18 years old) or parent and assent form if the participant is \<18 years old. * Stated willingness to comply with all study procedures and availability for the duration of the study * All sexes are eligible * Diagnosis of type 1 diabetes for at least 1 year * Insulin pump use for at least 2 months. * Ability to perform daily blood ketone checks, wear a continuous glucose monitor, willing to wear an activity monitor, willing to adhere to the study diets and keep a diet journal. * For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional 4 weeks after the end of the dietary intervention. * For males of reproductive potential: use of condoms or other methods to ensure effective contraception with partner

Exclusion criteria

* Current use of glucose-lowering agents other than insulin * Unstable psychiatric disorders, including eating disorders * Weight loss medications within the last 6 months * Pregnancy or lactation, or planning pregnancy within the next 6 months * BMI \< 19 kg/m2 for individuals 18 years of age or older * BMI \< 5%ile for individuals under 18 years * Weight less than 49 kg or 108 pounds * Other medical conditions that may interfere with glucose metabolism and insulin sensitivity

Design outcomes

Primary

MeasureTime frameDescription
Percent Time in the Optimal Glucose Range2 weeksTime in the optimal glucose range will be operationally defined as the percent time spent in the target range of 70-180 mg/dL during the 2 weeks.

Secondary

MeasureTime frameDescription
Percent Time Spent With Hypoglycemia.2 weeksTime spent with hypoglycemia will be operationally defined as the percent time spent in the hypoglycemic ranges during 2 weeks of diet. Level 2 hypoglycemia defined as \<54 mg/dL. Level 1 hypoglycemia defined as 54-69 mg/dL.
Percent Time Spent With Hyperglycemia2 weeksTime spent with hyperglycemia will be operationally defined as the percent time spent in the hyperglycemic ranges during 2 weeks of diet. Level 1 hyperglycemia defined as 181-250 mg/dL. Level 2 hyperglycemia defined as \>250 mg/dL.

Other

MeasureTime frameDescription
Human Factors8 weeeksTo describe how participants feel about and react to following a very low carbohydrate diet, interviews will be conducted. Data will be coded and emerging patterns will be combined into descriptive themes.

Countries

United States

Participant flow

Participants by arm

ArmCount
Low Carbohydrate Diet, Then Standard Carbohydrate Diet
In this crossover study, participants will be randomized to either a low or standard carbohydrate for 2 weeks. Participants in the low carbohydrate group will limit carbohydrate intake to 15% of total daily calories. low carbohydrate diet: Participants will engage in a diet that limits carbohydrate intake to 15% of total daily calories for 2 weeks.
9
Standard Carbohydrate Diet, Then Low Carbohydrate Diet
In this crossover study, participants will be randomized to either a low or standard carbohydrate for 2 weeks. Participants in the standard carbohydrate group will follow an ad libitum diet with standard carbohydrate intake. standard carbohydrate diet: Participants will engage in a diet that recommends standard carbohydrate intake with respect to total daily calories for 2 weeks.
10
Total19

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 2Discontinued intervention12

Baseline characteristics

CharacteristicLow Carbohydrate Diet, Then Standard Carbohydrate DietTotalStandard Carbohydrate Diet, Then Low Carbohydrate Diet
Age, Continuous17 years
STANDARD_DEVIATION 3
17 years
STANDARD_DEVIATION 2.57
17 years
STANDARD_DEVIATION 2.67
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants6 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants13 Participants7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
8 Participants15 Participants7 Participants
Region of Enrollment
United States
9 participants19 participants10 participants
Sex: Female, Male
Female
4 Participants7 Participants3 Participants
Sex: Female, Male
Male
5 Participants12 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 190 / 19
other
Total, other adverse events
8 / 198 / 191 / 19
serious
Total, serious adverse events
0 / 190 / 190 / 19

Outcome results

Primary

Percent Time in the Optimal Glucose Range

Time in the optimal glucose range will be operationally defined as the percent time spent in the target range of 70-180 mg/dL during the 2 weeks.

Time frame: 2 weeks

ArmMeasureValue (MEAN)
Low Carbohydrate DietPercent Time in the Optimal Glucose Range71.20 percentage of time
Standard Carbohydrate DietPercent Time in the Optimal Glucose Range62.51 percentage of time
p-value: <0.001t-test, 1 sided
Secondary

Percent Time Spent With Hyperglycemia

Time spent with hyperglycemia will be operationally defined as the percent time spent in the hyperglycemic ranges during 2 weeks of diet. Level 1 hyperglycemia defined as 181-250 mg/dL. Level 2 hyperglycemia defined as \>250 mg/dL.

Time frame: 2 weeks

ArmMeasureGroupValue (MEAN)
Low Carbohydrate DietPercent Time Spent With Hyperglycemia181-250 mg/dL19.93 percentage of time
Low Carbohydrate DietPercent Time Spent With Hyperglycemia>250 mg/dL7.19 percentage of time
Standard Carbohydrate DietPercent Time Spent With Hyperglycemia181-250 mg/dL23.20 percentage of time
Standard Carbohydrate DietPercent Time Spent With Hyperglycemia>250 mg/dL12.5 percentage of time
Comparison: 181-250 mg/dLp-value: 0.006t-test, 1 sided
Comparison: \>250 mg/dLp-value: <0.001t-test, 1 sided
Secondary

Percent Time Spent With Hypoglycemia.

Time spent with hypoglycemia will be operationally defined as the percent time spent in the hypoglycemic ranges during 2 weeks of diet. Level 2 hypoglycemia defined as \<54 mg/dL. Level 1 hypoglycemia defined as 54-69 mg/dL.

Time frame: 2 weeks

ArmMeasureGroupValue (MEAN)
Low Carbohydrate DietPercent Time Spent With Hypoglycemia.<54 mg/dL0.42 percentage of time
Low Carbohydrate DietPercent Time Spent With Hypoglycemia.54-69 mg/dL1.27 percentage of time
Standard Carbohydrate DietPercent Time Spent With Hypoglycemia.<54 mg/dL0.33 percentage of time
Standard Carbohydrate DietPercent Time Spent With Hypoglycemia.54-69 mg/dL1.46 percentage of time
Comparison: \<54 mg/dLp-value: 0.57t-test, 1 sided
Comparison: 54-69 mg/dLp-value: 0.43t-test, 1 sided
Other Pre-specified

Human Factors

To describe how participants feel about and react to following a very low carbohydrate diet, interviews will be conducted. Data will be coded and emerging patterns will be combined into descriptive themes.

Time frame: 8 weeeks

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026